Company Overview of Biomerk, Inc.
Biomerk, Inc. engages in the development of a preclinical platform of human cancer tumor immune-deficient mice xenografts. The company was founded in 2006 and is based in Scottsdale, Arizona. As of May 2007, Biomerk, Inc. operates as a subsidiary of Champions Biotechnology, Inc.
15111 North Hayden Road
Scottsdale, AZ 85260
Founded in 2006
Key Executives for Biomerk, Inc.
Similar Private Companies By Industry
|Muskogee Clinical Laboratory, Inc.||United States|
|Aegis Therapeutics, LLC||United States|
|Comgenex LLC||United States|
|Origen Therapeutics, Inc.||United States|
|Neurop, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York City, NY | BloombergPosted: Apr 14
- Delaware | DuPontPosted: Apr 11
- Gaithersburg, MD | MedimmunePosted: Apr 16
- New York | Shore ConsultantsPosted: Apr 14
Sponsored Financial Commentaries
To contact Biomerk, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.